Sadat Umar
Department of Surgery, Cambridge Vascular Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Box 201, Cambridge CB2 0QQ, UK.
ISRN Radiol. 2013 Sep 16;2013:496438. doi: 10.5402/2013/496438. eCollection 2013.
Contrast-induced acute kidney injury (CI-AKI) is one of the most widely discussed and debated topics in cardiovascular medicine. With increasing number of contrast-media- (CM-) enhanced imaging studies being performed and growing octogenarian population with significant comorbidities, incidence of CI-AKI remains high. In this review, pathophysiology of CI-AKI, its relationship with different types of CM, role of serum and urinary biomarkers for diagnosing CI-AKI, and various prophylactic strategies used for nephroprotection against CI-AKI are discussed in detail.
对比剂诱导的急性肾损伤(CI-AKI)是心血管医学中讨论和争议最为广泛的话题之一。随着使用对比剂(CM)增强成像研究的数量不断增加,以及患有严重合并症的八十多岁老年人口不断增多,CI-AKI的发病率仍然很高。在这篇综述中,将详细讨论CI-AKI的病理生理学、其与不同类型对比剂的关系、血清和尿液生物标志物在诊断CI-AKI中的作用,以及用于预防CI-AKI肾损伤的各种预防策略。